INVESTER I COGNITION THERAPEUTICS MED ENDAVU: Køb Cognition Therapeutics ($CGTX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Cognition Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for age-related degenerative diseases affecting the central nervous system and the retina. Its lead program centers on zervimesine (CT1812), an oral candidate designed to protect neuronal synapses and modulate disease-related protein interactions. The company is evaluating this candidate across multiple neuroscience and neuro-ophthalmology settings, including Alzheimer’s disease, mild cognitive impairment, dementia with Lewy bodies, and geographic atrophy associated with dry age-related macular degeneration. Cognition Therapeutics combines mechanistic research with translational and clinical development to address disorders linked to synaptic dysfunction and cellular stress. Headquartered in Purchase, New York, the company plays a specialized role in the biotech market as a developer of targeted treatments for complex neurodegenerative and retinal conditions.